Table 2.
Hyperviscosity phenotype, virulence, and drug resistance genes and capsular serotypes | ALL N = 169 (%) | T6SS-negative N = 108(%) | T6SS-positive N = 61 (%) | p.overall |
---|---|---|---|---|
Hyperviscosity phenotype | 81 (47.93) | 53 (49.07) | 28 (45.90) | 0.813 |
HvKp | 70 (41.42) | 32 (29.63) | 38 (62.30) | <0.001* |
Virulence genes | ||||
rmpA | 100 (59.17) | 54 (50.00) | 46 (75.41) | 0.002* |
rmpA2 | 81 (47.93) | 41 (37.96) | 40 (65.57) | 0.001* |
aerobactin | 96 (56.80) | 54 (50.00) | 42 (68.85) | 0.027* |
iroB | 98 (57.99) | 55 (50.93) | 43 (70.49) | 0.021* |
peg344 | 108 (63.91) | 66 (61.11) | 42 (68.85) | 0.401 |
mrkD | 169 (100.00) | 108 (100.00) | 61 (100.00) | 1.000 |
wcaG | 46 (27.22) | 5 (4.63) | 41 (67.21) | <0.001* |
ybts | 119(70.41) | 72 (66.67) | 47 (77.05) | 0.213 |
alls | 50 (29.59) | 9 (8.33) | 41 (67.21) | <0.001* |
kfu | 58 (34.32) | 20 (18.52) | 38 (62.30) | <0.001* |
entB | 154 (91.12) | 99 (91.67) | 55 (90.16) | 0.961 |
iutA | 101 (59.76) | 58 (53.70) | 43 (70.49) | 0.048 |
Drug resistance genes | ||||
NDM-1 | 1 (0.59) | 1 (0.93) | 0 (0.00) | 1.000 |
OXA-48 | 2 (1.18) | 1 (0.93) | 1 (1.64) | 1.000 |
TEM | 42 (24.85) | 29 (26.85) | 13 (21.31) | 0.538 |
KPC-2 | 26 (15.38) | 26 (24.07) | 0 (0.00) | <0.001* |
KPC | 26 (15.38) | 26 (24.07) | 0 (0.00) | <0.001* |
CTX-M | 19 (11.24) | 9 (8.26) | 10 (16.39) | 0.180 |
IMP | 0 (0) | 0 (0) | 0 (0) | - |
VIM | 0 (0) | 0 (0) | 0 (0) | - |
SHV | 169 (100.00) | 109 (100.00) | 61 (100.00) | 1.000 |
Capsular serotypes | ||||
K1 | 44 (26.04) | 4 (3.70) | 40 (65.57) | <0.001 |
K2 | 36 (21.30) | 35 (32.41) | 1 (1.64) | <0.001 |
K5 | 2 (1.18) | 2 (1.86) | 0 (0.00) | 0.537 |
K20 | 3 (1.78) | 3 (2.78) | 0 (0.00) | 0.554 |
K54 | 2 (1.18) | 2 (1.85) | 0 (0.00) | 0.537 |
K57 | 5 (2.96) | 3 (2.78) | 2 (3.28) | 1.000 |
K64 | 19 (11.24) | 19 (17.59) | 0 (0.00) | 0.001 |
p < 0.05 was considered to be statistically significant. Statistically significant values are identified in boldface.